EIF2AK3 and early-onset autosomal dominant Alzheimer disease: Additionally, pharmacological or genetic inhibition of PERK has been shown to be neuroprotective in Drosophila models of Parkinson’s disease, and mouse models of frontotemporal dementia and Alzheimer’s disease [106].